尿液检查市场规模、份额和成长分析（按检测方法、应用、最终用户和地区划分）—产业预测（2026-2033 年）

预计到 2024 年，全球尿液检查市场规模将达到 25.1 亿美元，到 2025 年将达到 26.2 亿美元，到 2033 年将达到 36.9 亿美元，预测期（2026-2033 年）的复合年增长率为 4.4%。

全球尿液检查市场正经历显着成长，这主要得益于医疗设备的进步以及糖尿病等慢性疾病的日益增加。医疗基础设施的不断改善和未被满足的医疗需求不断增加，推动了尿液分析仪、测试纸和质控液等产品的需求激增，尤其是在新兴市场。此外，政府主导的筛检计画对于早期发现肾臟和泌尿系统疾病至关重要，也进一步促进了市场成长。男性和女性尿道感染（UTI）的高发生率也促使人们需要进行尿液检查以识别各种健康问题。总体而言，随着医疗服务提供者优先开发和采用创新尿液检查技术，预计该市场将持续强劲成长。

推动全球尿液检查市场发展的因素

发展中地区尿道感染（UTI）的增加是推动全球尿液检查市场成长的关键因素。这些感染疾病可能导致严重的併发症，尤其是在分娩期间；如果不及时治疗，感染也会扩散到肾臟，因此迫切需要可靠的诊断解决方案。人们对泌尿道感染相关健康影响的认识不断提高，促使对高效尿液检查的需求增加，以便早期发现和治疗。这一趋势是由人们对健康的关注以及对改善医疗基础设施的需求共同推动的，预计将进一步促进市场发展。

全球尿液检查市场面临的限制因素

全球尿液检查市场面临严峻挑战，尤其是在价格敏感的发展中地区，消费者倾向于选择功能相当但价格较低廉的设备。缺乏健全的法规结构进一步加剧了这一趋势，导致大量不合格和翻新产品涌入市场。这些劣质产品不仅会降低医疗服务质量，还会危及病人安全和治疗效果。因此，这些市场对高品质、创新尿液检查解决方案的需求可能疲软，从而阻碍整体成长，并可能对公共卫生造成影响。

全球尿液检查市场趋势

在全球诊断技术进步的推动下，全球尿液检查市场正经历着变革性的转变。尿液分析仪的自动化以及基于智慧型手机的检测设备的集成，提高了尿液检查的准确性和便捷性，使患者和医疗服务提供者都能从中受益。随着糖尿病和肾臟病等慢性疾病的持续增长，对高效尿液检查方法的需求日益迫切，这对于疾病的早期发现和持续管理至关重要。这种不断变化的市场格局凸显了尿液检查在现代医学中的关键作用，巩固了其作为监测健康状况和改善患者预后的重要工具的地位。

目录

介绍

• 调查目标
• 调查范围
• 定义

调查方法

• 资讯收集
• 二手资料和一手资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分市场机会分析

市场动态与展望

• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特分析

关键市场考察

• 关键成功因素
• 竞争程度
• 关键投资机会
• 市场生态系统
• 市场吸引力指数（2025）
• PESTEL 分析
• 总体经济指标
• 价值链分析
• 定价分析

全球尿液检查市场规模（按检测类型和复合年增长率划分）（2026-2033 年）

• 妊娠和不孕症检查
• 尿液检查
• 尿液检查

全球尿液检查市场规模（按应用领域划分）及复合年增长率（2026-2033 年）

• 疾病筛检
• 怀孕和生育治疗

全球尿液检查市场规模（依最终用户划分）及复合年增长率（2026-2033 年）

• 医院和诊所
• 诊断检查室
• 居家医疗环境
• 研究实验室和机构

全球尿液检查市场规模及复合年增长率（2026-2033）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 亚太其他地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业的市场定位（2025 年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市占率分析（2025 年）
• 主要企业公司简介
  • 公司详情
  • 产品系列分析
  • 依业务板块进行公司股票分析
  • 2023-2025年营收年比比较

主要企业简介

• Cardinal Health（US）
• General Electric Company（US）
• Metropolis India（India）
• 77 Elektronika Kft（Hungary）
• Roche Diagnostics（Switzerland）
• Thermo Fisher Scientific（US）
• Sysmex Corporation（Japan）
• Abbott（US）
• Trinity Biotech（Ireland）
• ARKRAY Inc.（Japan）
• Dr Lal PathLabs（India）
• F. Hoffmann-La Roche Ltd（Switzerland）
• Siemens（Germany）
• Sysmex Corporation（Japan）
• BioMaxima SA（Poland）

结论与建议

Global Urinalysis Test Market size was valued at USD 2.51 Billion in 2024 and is poised to grow from USD 2.62 Billion in 2025 to USD 3.69 Billion by 2033, growing at a CAGR of 4.4% during the forecast period (2026-2033).

The global urinalysis test market is witnessing significant growth, propelled by advancements in medical equipment and the increasing prevalence of chronic diseases such as diabetes. Enhanced healthcare infrastructure and rising unmet healthcare needs are contributing to a surge in demand for urine analyzers, strips, and control solutions, particularly in emerging markets. Additionally, government-led screening programs are crucial for early detection of renal and urological issues, further stimulating market growth. The high incidence of urinary tract infections, prevalent among both men and women, is also driving the need for urinalysis testing to identify various health concerns. Overall, the market is positioned for robust expansion as healthcare providers prioritize the development and implementation of innovative urinalysis technologies.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Urinalysis Test market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Urinalysis Test Market Segments Analysis

Global Urinalysis Test Market is segmented by Application, End User, Test and region. Based on Test, the market is segmented into Pregnancy & Fertility Tests, Biochemical Urinalysis and Sediment Urinalysis. Based on Application, the market is segmented into Disease Screening and Pregnancy and Fertility. Based on End User, the market is segmented into Hospitals & Clinics, Diagnostic Laboratories, Home Care Setting and Research Laboratories & Institute. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Urinalysis Test Market

The increasing incidence of urinary tract infections (UTIs) in developing regions serves as a significant catalyst for the growth of the global urinalysis test market. These infections can lead to serious complications, particularly during childbirth, and may ascend to the kidneys if left untreated, highlighting the urgent need for reliable diagnostic solutions. As awareness of the health implications associated with UTIs rises, there is a growing demand for efficient urinalysis testing to facilitate early detection and treatment. This trend is expected to propel the market forward, driven by both health concerns and the need for improved healthcare infrastructure.

Restraints in the Global Urinalysis Test Market

The Global Urinalysis Test market faces significant challenges due to the preference for cost-effective devices with similar functionalities, particularly in price-sensitive developing regions. This trend is exacerbated by a lack of robust regulatory frameworks, which can lead to an influx of substandard and reconditioned products flooding the market. Such inferior goods not only undermine the quality of healthcare services but also pose risks to patient safety and treatment efficacy. Consequently, the demand for higher-quality and innovative urinalysis solutions may struggle in these markets, hindering overall growth and potentially affecting public health outcomes.

Market Trends of the Global Urinalysis Test Market

The Global Urinalysis Test market is witnessing a transformative shift driven by advancements in diagnostic technology. Automation in urine analyzers and the integration of smartphone-based testing devices are enhancing the accuracy and accessibility of urinalysis, facilitating easier testing for both patients and healthcare providers. As chronic conditions, such as diabetes and renal disease, continue to rise, the demand for effective urinalysis methods becomes increasingly vital for early detection and ongoing management. This evolving landscape underscores the critical role of urinalysis in contemporary healthcare, solidifying its status as an indispensable tool for monitoring health and improving patient outcomes.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Urinalysis Test Market Size by Test & CAGR (2026-2033)

• Market Overview
• Pregnancy & Fertility Tests
• Biochemical Urinalysis
• Sediment Urinalysis

Global Urinalysis Test Market Size by Application & CAGR (2026-2033)

• Market Overview
• Disease Screening
• Pregnancy and Fertility

Global Urinalysis Test Market Size by End User & CAGR (2026-2033)

• Market Overview
• Hospitals & Clinics
• Diagnostic Laboratories
• Home Care Setting
• Research Laboratories & Institute

Global Urinalysis Test Market Size & CAGR (2026-2033)

• North America (Application, End User, Test)
  • US
  • Canada
• Europe (Application, End User, Test)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Application, End User, Test)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Application, End User, Test)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Application, End User, Test)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Cardinal Health (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• General Electric Company (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Metropolis India (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• 77 Elektronika Kft (Hungary)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Roche Diagnostics (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sysmex Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Trinity Biotech (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ARKRAY Inc. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dr Lal PathLabs (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• F. Hoffmann-La Roche Ltd (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sysmex Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioMaxima SA (Poland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations